The LPS Receptor, CD14 in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis

Innate immune receptors are crucial for defense against microorganisms. Recently, a cross-talk between innate and adaptive immunity has been considered. Here, we provide first evidence for a role of the key innate immune receptor, LPS receptor (CD14) in pathophysiology of experimental autoimmune encephalomyelitis, the animal model of multiple sclerosis. Indicating a functional importance in vivo, we show that CD14 deficiency increased clinical symptoms in active experimental autoimmune encephalomyelitis. Consistent with these observations, CD14 deficient mice exhibited a markedly enhanced infiltration of monocytes and neutrophils in brain and spinal cord. Moreover, we observed an increased immunoreactivity of CD14 in biopsy and post mortem brain tissues of multiple sclerosis patients compared to age-matched controls. Thus, the key innate immune receptor, CD14, may be of pathophysiological relevance in experimental autoimmune encephalomyelitis and multiple sclerosis.

[1]  Ruslan Medzhitov,et al.  Control of B-cell responses by Toll-like receptors , 2005, Nature.

[2]  W. Seeger,et al.  Anti‐proteinase 3 antibodies (c‐ANCA) prime CD14‐dependent leukocyte activation , 2005, Journal of leukocyte biology.

[3]  K. Frei,et al.  CD14 deficiency leads to increased MIP‐2 production, CXCR2 expression, neutrophil transmigration, and early death in pneumococcal infection , 2005, Journal of leukocyte biology.

[4]  S. Cassel,et al.  Understanding asthma pathogenesis: linking innate and adaptive immunity , 2004, Current opinion in pediatrics.

[5]  P. Kubes,et al.  TLR4 Contributes to Disease-Inducing Mechanisms Resulting in Central Nervous System Autoimmune Disease1 , 2004, The Journal of Immunology.

[6]  Yongsoo Park,et al.  Association of the Polymorphism for Toll‐like Receptor 2 with Type 1 Diabetes Susceptibility , 2004, Annals of the New York Academy of Sciences.

[7]  R. Medzhitov,et al.  Toll-dependent control mechanisms of CD4 T cell activation. , 2004, Immunity.

[8]  V. Kuchroo,et al.  Activation of antigen-presenting cells by microbial products breaks self tolerance and induces autoimmune disease. , 2004, The Journal of clinical investigation.

[9]  H. Kolb,et al.  Combined activation of innate and T cell immunity for recognizing immunomodulatory properties of therapeutic agents , 2004, Journal of leukocyte biology.

[10]  K. Ishii,et al.  The LPS receptor (CD14) links innate immunity with Alzheimer's disease , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[11]  K. Mills,et al.  Toll-Like Receptor 4-Mediated Innate IL-10 Activates Antigen-Specific Regulatory T Cells and Confers Resistance to Bordetella pertussis by Inhibiting Inflammatory Pathology 1 , 2003, The Journal of Immunology.

[12]  H. Lassmann,et al.  Neuropathology of multiple sclerosis—new concepts , 2003, Brain Research Bulletin.

[13]  F. Weber,et al.  The macrophage activity marker sCD14 is increased in patients with multiple sclerosis and upregulated by interferon beta-1b , 2002, Journal of Neuroimmunology.

[14]  D. Feinstein,et al.  The Clinical Course of Experimental Autoimmune Encephalomyelitis is Associated with a Profound and Sustained Transcriptional Activation of the Genes Encoding Toll‐like Receptor 2 and CD14 in the Mouse CNS , 2002, Brain pathology.

[15]  H. Hartung,et al.  New concepts in the immunopathogenesis of multiple sclerosis , 2002, Nature Reviews Neuroscience.

[16]  T. Kaisho,et al.  Immunology: Bug detectors , 2001, Nature.

[17]  B. Beutler,et al.  Sepsis and evolution of the innate immune response. , 2001, Critical care medicine.

[18]  C. Weyand,et al.  CD4+,CD28- T cells in rheumatoid arthritis patients combine features of the innate and adaptive immune systems. , 2001, Arthritis and rheumatism.

[19]  S. McColl,et al.  Treatment with anti-granulocyte antibodies inhibits the effector phase of experimental autoimmune encephalomyelitis. , 1998, Journal of immunology.

[20]  M. Hennerici,et al.  Increased release of interleukin-12p40 in MS , 1998, Neurology.

[21]  B. Engelhardt,et al.  E- and P-selectin are not involved in the recruitment of inflammatory cells across the blood-brain barrier in experimental autoimmune encephalomyelitis. , 1997, Blood.

[22]  C. Janeway,et al.  A human homologue of the Drosophila Toll protein signals activation of adaptive immunity , 1997, Nature.

[23]  R. Ulevitch,et al.  Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. , 1995, Annual review of immunology.

[24]  M. Freeman,et al.  Surface expression of human CD14 in Chinese hamster ovary fibroblasts imparts macrophage-like responsiveness to bacterial endotoxin. , 1993, The Journal of biological chemistry.

[25]  N. Christou,et al.  Neutrophil priming by lipopolysaccharide involves heterogeneity in calcium-mediated signal transduction. Studies using fluo-3 and flow cytometry. , 1993, Journal of immunology.

[26]  R. Hughes.  Pathogenesis of multiple sclerosis. , 1992, Journal of the Royal Society of Medicine.

[27]  R. Ulevitch,et al.  CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. , 1990, Science.

[28]  N. Hogg,et al.  Colony‐stimulating factors and interferon‐gamma differentially affect cell surface molecules shared by monocytes and neutrophils , 1990, Clinical and experimental immunology.

[29]  M. L. Le Beau,et al.  The CD14 monocyte differentiation antigen maps to a region encoding growth factors and receptors. , 1988, Science.

[30]  J. Mussini,et al.  [Immunology of multiple sclerosis]. , 1982, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris.